UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $694,671 | -98.4% | 60,617 | -97.1% | 0.03% | -98.6% |
| Q1 2023 | $42,496,810 | -18.6% | 2,110,070 | -8.4% | 1.88% | +0.4% |
| Q4 2022 | $52,193,458 | +16.2% | 2,302,314 | -3.8% | 1.87% | +15.1% |
| Q3 2022 | $44,899,000 | +7.7% | 2,393,311 | +7.0% | 1.62% | +2.1% |
| Q2 2022 | $41,686,000 | +331.5% | 2,236,370 | +318.3% | 1.59% | +340.4% |
| Q1 2022 | $9,661,000 | -78.8% | 534,624 | -53.9% | 0.36% | -73.2% |
| Q3 2019 | $45,606,000 | +233.9% | 1,158,694 | +563.0% | 1.35% | +420.1% |
| Q2 2019 | $13,657,000 | -45.1% | 174,754 | -58.1% | 0.26% | -52.9% |
| Q1 2019 | $24,866,000 | – | 416,862 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |